Your browser doesn't support javascript.
loading
Impact of nodular calcification in patients with acute coronary syndrome (ACS) treated with primary percutaneous coronary intervention (PCI).
Demuyakor, Abigail; Hu, Sining; Koniaeva, Ekaterina; Liu, Minghao; Weng, Ziqian; Zhao, Chen; Feng, Xue; He, Luping; Xu, Yishuo; Zeng, Ming; Meng, Wei; Sun, Yanli; Yi, Boling; Gao, Zhanqun; Qin, Yuhan; Jia, Haibo; Mintz, Gary S; Yu, Bo.
Afiliação
  • Demuyakor A; Director of Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Director of The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, 246 Xuefu Rd., Harbin, 150086, China.
  • Hu S; Director of Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Director of The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, 246 Xuefu Rd., Harbin, 150086, China.
  • Koniaeva E; Director of Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Director of The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, 246 Xuefu Rd., Harbin, 150086, China.
  • Liu M; Director of Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Director of The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, 246 Xuefu Rd., Harbin, 150086, China.
  • Weng Z; Director of Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Director of The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, 246 Xuefu Rd., Harbin, 150086, China.
  • Zhao C; Director of Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Director of The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, 246 Xuefu Rd., Harbin, 150086, China.
  • Feng X; Director of Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Director of The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, 246 Xuefu Rd., Harbin, 150086, China.
  • He L; Director of Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Director of The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, 246 Xuefu Rd., Harbin, 150086, China.
  • Xu Y; Director of Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Director of The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, 246 Xuefu Rd., Harbin, 150086, China.
  • Zeng M; Director of Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Director of The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, 246 Xuefu Rd., Harbin, 150086, China.
  • Meng W; Director of Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Director of The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, 246 Xuefu Rd., Harbin, 150086, China.
  • Sun Y; Director of Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Director of The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, 246 Xuefu Rd., Harbin, 150086, China.
  • Yi B; Director of Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Director of The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, 246 Xuefu Rd., Harbin, 150086, China.
  • Gao Z; Director of Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Director of The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, 246 Xuefu Rd., Harbin, 150086, China.
  • Qin Y; Director of Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Director of The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, 246 Xuefu Rd., Harbin, 150086, China.
  • Jia H; Director of Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Director of The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, 246 Xuefu Rd., Harbin, 150086, China.
  • Mintz GS; Cardiovascular Research Foundation, New York, NY, USA.
  • Yu B; Director of Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Director of The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, 246 Xuefu Rd., Harbin, 150086, China. yubodr@163.com.
BMC Cardiovasc Disord ; 22(1): 103, 2022 03 14.
Article em En | MEDLINE | ID: mdl-35287572
ABSTRACT

BACKGROUND:

Calcified plaque is thought to adversely impact outcomes after percutaneous coronary intervention (PCI). This study sought to evaluate the impact of nodular calcification in patients with acute coronary syndrome treated with primary percutaneous coronary intervention.

METHODS:

Using optical coherence tomography (OCT), 500 culprit plaques with calcification were analyzed from 495 acute coronary syndrome (ACS) patients on whom PCI was performed. Based on morphology, we classified calcification into two subtypes nodular calcification and non-nodular calcification. Nodular calcification was defined as protruding mass with an irregular surface, high backscattering, and signal attenuation while non-nodular calcification was defined as an area with low backscattering heterogeneous region with a well-delineated border without protrusion into the lumen on OCT.

RESULTS:

Calcified culprit plaques were divided into nodular calcification group (n = 238) and non-nodular calcification group (n = 262). Patients with nodular calcification were older (p < 0.001) and had lower left ventricular ejection fraction (p = 0.006) compared to patients with non-nodular calcification. Minimum stent area (5.0 (3.9, 6.3) mm2 vs. 5.4 (4.2, 6.7) mm2, p = 0.011) and stent expansion (70 (62.7, 81.8) % vs. 75 (65.2, 86.6) %, p = 0.004) were significantly smaller in the nodular calcification group than in the non-nodular calcification group. Stent under-expansion was most frequent (p = 0.003) in the nodular calcification group.

CONCLUSION:

This study demonstrate that the presence of nodular calcification is associated with a smaller minimum stent area and a higher incidence of stent under-expansion. Lesions with nodular calcification may be at risk of stent under-expansion.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Síndrome Coronariana Aguda / Placa Aterosclerótica / Calcificação Vascular / Intervenção Coronária Percutânea Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Síndrome Coronariana Aguda / Placa Aterosclerótica / Calcificação Vascular / Intervenção Coronária Percutânea Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article